Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome
Open Access
- 1 February 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 14 (2) , 409-415
- https://doi.org/10.1093/humrep/14.2.409
Abstract
To test the hypothesis that dimeric inhibin A and/or inhibin B concentrations represent improved markers of in-vitro fertilization (IVF) outcome over follicle stimulating hormone (FSH), 78 women who achieved pregnancy within three assisted reproduction treatment cycles were matched to 78 women who underwent at least three assisted reproductive treatment cycles and failed to achieve pregnancy. Baseline serum inhibin B and FSH were obtained between days 1 and 4 in a cycle prior to ovarian stimulation, and inhibin A and B were measured immediately before the ovulatory stimulus and in follicular fluid from the lead follicle. Comparing pregnant and non-pregnant subjects at baseline, younger age (34.0 ± 0.5 versus 36.0 ± 0.5 years; P < 0.003) and a combination of FSH lower than the median value (11.2 IU/l) and inhibin B higher than the median value (76.5 pg/ml) were associated with pregnancy (P < 0.03), but FSH (11.7 ± 0.5 versus 12.9 ± 0.9 IU/ml) and inhibin B (89.0 ± 10.2 versus 79.7 ± 7.7 pg/ml) were not independently associated. At the time of the ovulatory stimulus, serum inhibin A (52.8 ± 3.8 versus 40.0 ± 2.7 IU/ml; P < 0.004), inhibin B (1623.8 ± 165.1 versus 859.2 ± 94.8 pg/ml; P < 0.0009) and the number of oocytes retrieved (14.6 ± 0.8 versus 10.1 ± 0.6; P < 0.0001) were predictive of pregnancy when controlled for age. Inhibin A was correlated with the number of embryos (r = 0.4; P < 0.0001). However, neither inhibin A nor inhibin B provided additional information in predicting successful outcome over age and number of oocytes. We conclude that: (i) in patients undergoing assisted reproductive technology, age and number of oocytes retrieved are the strongest predictors of success; (ii) of the parameters available prior to cycle initiation, a combination of lower FSH and higher inhibin B was associated with a greater chance for a successful outcome but an absolute cut-off could not be defined; and (iii) during ovarian stimulation, higher concentrations of inhibin A and inhibin B in serum are associated with successful IVF and mark ovarian reserve as a measure of oocyte number and quality.Keywords
This publication has 37 references indexed in Scilit:
- Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cyclesJournal of Clinical Endocrinology & Metabolism, 1996
- Measurement of dimeric inhibin B throughout the human menstrual cycleJournal of Clinical Endocrinology & Metabolism, 1996
- Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women.Proceedings of the National Academy of Sciences, 1994
- Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme- linked immunosorbent assayJournal of Clinical Endocrinology & Metabolism, 1994
- Detection of dimeric inhibin throughout the human menstrual cycle by two‐site enzyme immunoassayClinical Endocrinology, 1994
- Dehydroepiandrosterone sulfate and anovulation increase serum inhibin and affect follicular function during administration of gonadotropinsJournal of Clinical Endocrinology & Metabolism, 1994
- Follicular fluid inhibin levels in relation to age in patients in an in vitro fertilization and embryo transfer programmeEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
- Control of immunoactive inhibin production by human granulosa cellsClinical Endocrinology, 1991
- Inhibin and Estradiol Responses to Ovarian Hyperstimultion: Effects of Age and Predictive Value forin VitroFertilization OutcomeJournal of Clinical Endocrinology & Metabolism, 1990
- The Biologic Activity of a Potent Analogue of Gonadotropin-Releasing Hormone in Normal and Hypogonadotropic MenNew England Journal of Medicine, 1980